Manyahi J, Matee M.I, Majigo M,Moyo S, Mshana S.E, Lyamuya E.F,2014. Predominance of multi-drug resistant bacterial pathogens causing surgical site infections in Muhimbili national hospital, Tanzania. BMC Res Notes. 7:500
Neil W, Jane F, T, David M, 2011. Multiresistant Gram negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance. FEMs Microbiology Rev. 35 (5): 736-755.
Magiorakos A.P, Srinivasan, Carey R.B, Carmeli Y, Faragas M.E, Giske C.G, Harbarth S, Hindler J.F, Kahlmeter,Olsson-Liljequist B, Paterson D.L, Rice L.B, Stelling J, StruelensM.J, Vatopoulos A, Weber J.T, Monnet D.L, 2011. Multidrug- resistant, extensively drug- resistant and pandrug resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clinical Microbiology infection. 18: 268-281.
Moyo S, Aboud S, Kasubi M, Maselle S.Y, 2010. Bacteria isolated from blood stream infections at a tertiary hospital in Dar es Salaam, Tanzania-antimicrobial resistance of isolates. South African Medical Journal. 100(12):2078-5135.
Lukac P.J, Bonomo R.A, Logan L.K, 2015. Extended –Spectrum Beta-lactamase-producing Enterobacteriaceae in children: old Foe Emerging Threat. Healthcare epidemiology. 60(1):1389.
Souli M, Galani I, Giamarellou H, 2008. Emergence of extensively drug- resistance and pandrug- resistant Gram- negative bacilli in Europe. Europe PMC 13(47): 5437-5453.
Alshara M, 2011.Antimicrobial resistant pattern of Escherichia coli strains isolated from pediatric patients in Jordan. Acta Medica, Iranica. 49(5):293-295.
Bryce A, Hay A.D, Lane I.F, Thornton H.V, Wootton M, Costelloe C, 2016. Global prevalence of antibiotic resistance in paediatric urinary tract infections caused by Escherichia coli and association with routine use of antibiotics in primary care: systematic reviewand meta-analysis. BMJ;352:i939http://dx.doi.org/10.1136/bmj.i939.
Mshana S.E, Kamugisha E, Mirambo M, Chakraborty T, Lyamuya E.F,2009. Prevalence of multiresistant gram-negative organisms in a tertiary hospital in Mwanza, Tanzania. BMC Research Notes. 2:49 DOI: 10.1186/1756-0500-2-49
Hawkey P.M, Jones A.M, 2009. The changing epidemiology of resistance. Journal of Antimicrobial Chemotherapy. 64(1): i3-10. doi: 10.1093/jac/dkp256.
Ahmed M, Moremi N, Mirambo M.M, Hokororo A, Mushi M.F, Seni J, Kamugisha E, Mshana S.E, 2015.Multi-resistant gram negative enteric bacteria causing urinary tract infection among malnourished underfives admitted at a tertiary hospital, northwestern, Tanzania. Italian Journal of Pediatrics. 41:44 doi: 10.1186/s13052-015-0151-5 PMCID: PMC4472394.
Colomb-Cotinat M, Lacoste J, Brun-Buisson C, Jarlier V, Coignard B, Vaux S, 2016. Estimating the morbidity associated with infections due to multidrug-resistant bacteria (MDRB), France. Antimicrobial Resistance infection control. 5:56. Doi: 10.1186/s13756-016-0154-z.
WHO,2018. Global Antimicrobial Surveillance.
Tadesse B.T, Ashley E.A, Ongarello S, Havumaki J, Wijegoonewardena M, Gonzalez I.J, Dittrich S, 2017. Antimicrobial resistance in Africa; a systematic review. BMC Infectious Diseases. 17:616. Doi: 10.1186/s12879-017-2713-1.
Moremi N, Claus H, Mshana S.E, 2016. Antimicrobial resistance pattern: a report of microbiological cultures at a tertiary hospital in Tanzania. BMC infectious Disease. 16:756. DOI 10.1186/s12879-016-2082-1.
Drieux L, Brossier F, Sougakoff W, Jorlier V, 2008. Phenotypic detection of extended – spectrum beta- lactamase production in Enterobacteriaceae: review and bench guide. Clinical Microbiology and infection. 14(1):90-103.
Tanzania MOHCDGEC Standard treatment guideline and National essential Medicines list Tanzania Mainland, 2017; pg 419-420.
Bergman M, Nyberg S.T, Huovinen P,Paakkari P, Hakanen A.J,2009. Association between antimicrobial consumption and resistance in Escherichia coli. American Society for Microbiology. 53(3):912-917.
Ayatollahi J,Shahcheraghi S.H, Akhondi R, Soluti S.S, 2013. Antibiotic resistance patterns of Escherichia coli isolated from children in Shahid Sadoughi Hospital of Yazd. Iranian Journal of Pediatric Hematology oncology. 3(2):78-82
Bindayna K.M, Senok A.C, Jamsheer A.E, 2009. Prevalence of extended spectrum beta-lactamase producing enterobacteriaceae in Bahrain. Journal of Infection and Public Health. 2:129-135.
Kehl S.C, Dowzicky M.J, 2015. Global Assessment of Antimicrobial Susceptibility among Gram-Negative Organisms Collected from Pediatric Patients between 2004and 2012: Results from the Tigecycline Evaluation and SurveillanceTrial. Journal of Clinical Microbiology. 53:1286-1293.
Tellevik MG, Blomberg B, Kommedal Ø, Maselle SY, Langeland N, Moyo SJ, 2016. High Prevalence of Faecal Carriage of ESBL-Producing Enterobacteriaceae among Children in Dar es Salaam, Tanzania. PLoS ONE. 11(12): e0168024. https://doi.org/10.1371/journal.pone.0168024.
Ntirenganya C, Manzi D, Mavunyi C.M, Ogbuaga O, 2015. High prevalence antimicrobial resistance among common bacterial isolates in a tertiary Healthcare Facility in Rwanda. American Journal of Tropical Medicine and Hygiene. 94(4):865-870.
Zerr D.M, Miles-Jay A, Kronman M.P, Zhou C, Adler A.L, Haaland W,Weissman S.J, Elward A, Newland J.G, Zaoutis T, Qin X, 2016. Previous antibiotic exposure increases risk of infection with extended-spectrum beta lactamase and AmpC-producing Escherichia coli and Klebsiella pneumoniae in pediatric patients. Antimicrobial Agents Chemotherapy.60:4237–4243. doi:10.1128/AAC.00187-16.
Dohmen W, Dorado-García A, Bonten M.J.M, Wagenaar J.A, Mevius D, Heederik D.J.J, 2017. Risk factors for ESBL-producing Escherichia coli on pig farms: A longitudinal study in the context of reduced use of antimicrobials. PloS ONE. 12(3):e0174094. https://doi.org/10.1371/journal.pone.0174094.